Lazard Asset Management’s Gyre Therapeutics GYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-833
| Closed | -$6K | – | 2387 |
|
|
2025
Q1 | $6K | Buy |
+833
| New | +$6K | ﹤0.01% | 2174 |
|
|
2023
Q1 | – | Sell |
-53,221
| Closed | -$28K | – | 2406 |
|
|
2022
Q4 | $28K | Buy |
53,221
+7,249
| +16% | +$3.81K | ﹤0.01% | 2054 |
|
|
2022
Q3 | $23K | Buy |
+45,972
| New | +$23K | ﹤0.01% | 2063 |
|